SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001193125-24-126495
Filing Date
2024-05-01
Accepted
2024-05-01 08:54:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 FWP d774782dfwp.htm FWP 27059
  Complete submission text file 0001193125-24-126495.txt   28892
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filed by) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: FWP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Subject) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-265470 | Film No.: 24900286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)